Cadrenal Therapeutics Inc [CVKD] stock is trading at $0.52, up 3.82%. An important factor to consider is whether the stock is rising or falling in short-term value. The CVKD shares have gain 25.45% over the last week, with a monthly amount glided 15.21%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cadrenal Therapeutics Inc [NASDAQ: CVKD] stock has seen the most recent analyst activity on December 18, 2023, when Noble Capital Markets initiated its Outperform rating and assigned the stock a price target of $4.
Cadrenal Therapeutics Inc [CVKD] stock has fluctuated between $0.36 and $2.17 over the past year. Cadrenal Therapeutics Inc [NASDAQ: CVKD] shares were valued at $0.52 at the most recent close of the market.
Analyzing the CVKD fundamentals
Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -2394.75%, Pretax Profit Margin comes in at -2253.17%, and Net Profit Margin reading is -2253.17%. To continue investigating profitability, this company’s Return on Assets is posted at -1.14, Equity is -0.94 and Total Capital is -1.66. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4723 points at the first support level, and at 0.4255 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5885, and for the 2nd resistance point, it is at 0.6579.
Ratios To Look Out For
For context, Cadrenal Therapeutics Inc’s Current Ratio is 3.60. On the other hand, the Quick Ratio is 3.60, and the Cash Ratio is 3.44.
Transactions by insiders
Recent insider trading involved MURPHY JOHN RAYMOND, Director, that happened on Oct 04 ’23 when 17331.0 shares were purchased. Director, MURPHY JOHN RAYMOND completed a deal on Oct 05 ’23 to buy 2669.0 shares. Meanwhile, CEO and Chairman Pham Quang X bought 40000.0 shares on Sep 05 ’23.
